Category: MassDevice.com Earnings RoundupSyndicate content

Ex-Stryker CFO Hartman takes over at ConMed

July 23, 2014 by Arezu Sarvestani

ConMed names former Stryker CFO Curt Hartman interim CEO and lowers its outlook for the rest of the year.

Former Styker CFO takes over at ConMED

Surgical device maker ConMed (NSDQ:CNMD) took a major hit on Wall Street today after announcing some turnover at the top and lowering its financial outlook for the rest of the year.

Intuitive Surgical's Q2 profits tank but still beat expectations

July 22, 2014 by Arezu Sarvestani

Troubled Intuitive Surgical manages to blow away Wall Street's expectations, even as Q2 profits drop 35% year-over-year.

Intuitive Surgical's profits tank but still beat expectations

California device maker Intuitive Surgical (NSDQ:ISRG) got a major after-hours boost after reporting Q2 numbers that, while still down year-over-year, beat Wall Street's expectations by a mile.

Abbott raises full-year guidance on strong Q2, but medtech lags

July 18, 2014 by Arezu Sarvestani

Abbott Labs reports a strong 2nd quarter driven in large part by diagnostics, but the medical device segment took a hit in U.S. sales, leading to a pretty flat quarter.

Abbott raises full-year guidance, but medtech numbers fail to impress

Illinois-based Abbott (NYSE:ABT) released a 2nd-quarter earnings report showing some strong momentum, but the healthcare giant's medical device sector didn't fare so well.

GE Healthcare idles for another quarter

July 18, 2014 by Arezu Sarvestani

Industry giant GE posts another lackluster quarter for its healthcare business with flat sales and profits for Q2 and low expectations for the rest of the year.

GE Healthcare idles for another quarter

GE Healthcare (NYSE:GE) isn't terribly optimistic about its prospects for the rest of this year as its 2nd-quarter earnings report again shows softness in the U.S. dragging down total healthcare activity.

Stryker's Q2 earnings meet The Street

July 17, 2014 by Brad Perriello

Stryker Corp. reports 2nd-quarter earnings that meet Wall Street's expectations, despite flat profit growth on 7% sales growth.

Stryker's Q2 earnings meet The Street

Stryker (NYSE:SYK) said today that its 2nd-quarter earnings met expectations on Wall Street, despite flat profit growth, on 7% sales growth.

Baxter reports Q2 sales jump, narrows earnings guidance

July 17, 2014 by Brad Perriello

Baxter reports 2nd-quarter sales growth of more than 16% and beats earnings expectations, but narrows its full-year earnings guidance.

Baxter reports Q2 sales jump, narrows earnings guidance

Abbott reports meager medical device sales growth despite Q2 beats

July 16, 2014 by Brad Perriello

Abbott's medical device business posts meager growth for the 2nd quarter, despite overall sales and earnings coming in ahead of expectations.

Abbott reports meager medical device sales growth despite Q2 beats

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp